Quick Answer
iBio, Inc. reported Cash And Cash Equivalents At Carrying Value of $8.58 million for the year ending 2025.
- iBio, Inc. showed a decrease of -39.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from iBio, Inc.'s annual report (Form 10-K), filed with the SEC on September 5, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $3.84 million | Q3 2011: $1.52 million | Q4 2011: $623.5 thousand | Q1 2012: $6.72 million | Q3 2012: $4.28 million | Q4 2012: $2.82 million | Q1 2013: $1.53 million | Q3 2013: $3.44 million | Q4 2013: $5.68 million | Q1 2014: $4.33 million | Q3 2014: $3.49 million | Q4 2014: $7.36 million | Q1 2015: $8.08 million | Q3 2015: $8.38 million | Q4 2015: $6.73 million | Q1 2016: $21.89 million | Q3 2016: $20.10 million | Q4 2016: $16.33 million | Q1 2017: $12.42 million | Q3 2017: $5.92 million | Q4 2017: $7.31 million | Q1 2018: $3.40 million | Q2 2018: $4.42 million | Q3 2018: $8.16 million | Q4 2018: $13.36 million | Q1 2019: $9.04 million | Q3 2019: $2.10 million | Q4 2019: $3.64 million | Q1 2020: $10.04 million | Q2 2020: $55.11 million | Q3 2020: $77.54 million | Q4 2020: $91.25 million | Q1 2021: $84.63 million | Q3 2021: $62.82 million | Q4 2021: $39.21 million | Q1 2022: $33.77 million | Q3 2022: $9.89 million | Q4 2022: $3.70 million | Q1 2023: $6.56 million | Q3 2023: $1.46 million | Q4 2023: $2.79 million | Q1 2024: $5.30 million | Q3 2024: $11.04 million | Q4 2024: $7.02 million | Q1 2025: $4.96 million | Q2 2025: $8.58 million | Q3 2025: $28.11 million | Q4 2025: $28.67 million.
- Over the full 15 years of available data (2011 to 2025), iBio, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 201.9%.
- Historical annual values: Fiscal year 2025: $8.58 million | Fiscal year 2024: $14.21 million | Fiscal year 2023: $4.30 million | Fiscal year 2022: $22.68 million | Fiscal year 2021: $77.40 million | Fiscal year 2020: $55.11 million | Fiscal year 2019: $4.42 million | Fiscal year 2018: $4.42 million | Fiscal year 2017: $15.93 million | Fiscal year 2016: $15.93 million | Fiscal year 2015: $9.49 million | Fiscal year 2014: $3.59 million | Fiscal year 2013: $4.41 million | Fiscal year 2012: $5.62 million | Fiscal year 2011: $2.84 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: